| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 氨基酸类原料药(元) | 142,561,890.39 | 295,663,386.85 | 156,693,845.00 | 366,469,147.69 | 197,874,570.27 |
| 甾体激素类(元) | 992,279,766.72 | 1,731,606,124.55 | 1,061,437,479.76 | 2,083,406,706.22 | 1,086,379,737.87 |
| 其他(元) | 444,403,721.41 | 1,162,253,751.68 | 569,074,671.24 | 1,305,470,740.52 | 719,474,132.52 |
| 营业成本(元) | |||||
| 氨基酸类原料药(元) | 79,619,009.78 | 175,130,310.52 | 86,976,722.96 | 192,734,174.52 | 89,454,892.27 |
| 甾体激素类(元) | 590,898,940.39 | 1,078,938,356.19 | 683,940,854.34 | 1,399,445,994.81 | 719,124,678.57 |
| 其他(元) | 247,693,341.32 | 474,336,033.95 | 185,520,924.36 | 414,386,130.61 | 169,703,565.64 |
| 毛利(元) | |||||
| 氨基酸类原料药(元) | 62,942,880.61 | 120,533,076.33 | 69,717,122.04 | 173,734,973.17 | 108,419,678.00 |
| 甾体激素类(元) | 401,380,826.33 | 652,667,768.36 | 377,496,625.42 | 683,960,711.41 | 367,255,059.30 |
| 其他(元) | 196,710,380.09 | 687,917,717.73 | 383,553,746.88 | 891,084,609.91 | 549,770,566.88 |
| 毛利率(%) | |||||
| 氨基酸类原料药(%) | 44.15 | 40.77 | 44.49 | 47.41 | 54.79 |
| 甾体激素类(%) | 40.45 | 37.69 | 35.56 | 32.83 | 33.81 |
| 其他(%) | 44.26 | 59.19 | 67.40 | 68.26 | 76.41 |
| 收入构成(%) | |||||
| 氨基酸类原料药(%) | 9.03 | 9.27 | 8.77 | 9.76 | 9.88 |
| 甾体激素类(%) | 62.83 | 54.29 | 59.39 | 55.48 | 54.22 |
| 其他(%) | 28.14 | 36.44 | 31.84 | 34.76 | 35.91 |
| 毛利构成(%) | |||||
| 氨基酸类原料药(%) | 9.52 | 8.25 | 8.39 | 9.93 | 10.57 |
| 甾体激素类(%) | 60.72 | 44.67 | 45.44 | 39.11 | 35.81 |
| 其他(%) | 29.76 | 47.08 | 46.17 | 50.95 | 53.61 |